Outset Medical is a medical technology company based in San Jose, California, focused on developing integrated systems for kidney dialysis. Its core product, the Tablo Hemodialysis System, is an FDA-cleared device that consolidates water purification, dialysate production, and treatment delivery into a single console. The system is designed for use in hospitals and, with its recent clearance for all care settings, in home environments as well.
The Tablo system addresses significant operational challenges in dialysis delivery. It requires no special infrastructure for installation and is designed for rapid staff training, with nurses learning to operate it in hours. The device incorporates wireless data transfer, a touchscreen interface for guided treatment, and automated clinical documentation. It is designed to manage approximately 95% of hospital dialysis treatments.
Adoption of the technology has scaled to nearly 1,000 hospitals and health systems across North America that have insourced their acute dialysis programs. The company manufactures in North America and employs over 500 people. Its technical work spans medical device engineering, cloud-connected systems, water purification, and treatment automation.
